|
⚲
|
| Keyboard |
| 20/20 Biolabs Inc
✚
|
|
|---|---|
| CIK # | 0001139685 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 10-K | [0001139685] | |
| 10-Q | [0001139685] | |
| 3 | [0001139685] | |
| 4 | [0001139685] | |
| 8-K | [0001139685] | |
| D | [0001139685] | |
| SC 13D | [0001139685] | |
| SC 13G | [0001139685] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Full Succeed International Ltd | 20/20 Biolabs Inc | [2026-03-10] |
| Cohen Jonathan M | 20/20 Biolabs Inc | [2026-03-10] |
| Streeterville Capital LLC | 20/20 Biolabs Inc | [2026-02-25] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
20/20 Biolabs Inc AIDX
Stock Option · derivative
|
2026-03-03 | Grant | 352,936 | $0.00 | |
|
20/20 Biolabs Inc AIDX
Series A-2 Preferred Stock · derivative
|
2026-02-19 | Conversion | 7,700 | ||
|
20/20 Biolabs Inc AIDX
Common Stock
|
2026-02-19 | Conversion | 7,669 | $0.00 | |
|
20/20 Biolabs Inc AIDX
Series A-2 Preferred Stock · derivative
|
2026-02-19 | Conversion | 7,669 | ||
|
20/20 Biolabs Inc AIDX
Common Stock
|
2026-02-19 | Conversion | 31 | $0.00 | |
|
20/20 Biolabs Inc AIDX
Common Stock
|
2026-02-19 | Conversion | 7,700 | $0.00 | |
|
20/20 Biolabs Inc AIDX
Common Stock
|
2026-02-19 | Conversion | 13,029 | $0.00 | |
|
20/20 Biolabs Inc AIDX
Common Stock
|
2026-02-19 | Conversion | 6,135 | $0.00 | |
|
20/20 Biolabs Inc AIDX
Series A Preferred Stock · derivative
|
2026-02-19 | Conversion | 13,029 | ||
|
20/20 Biolabs Inc AIDX
Series A-2 Preferred Stock · derivative
|
2026-02-19 | Conversion | 6,135 | ||
|
20/20 Biolabs Inc AIDX
Series A-2 Preferred Stock · derivative
|
2026-02-19 | Conversion | 31 |